Aurinia names Kevin Tang as new CEO

Aurinia Pharmaceuticals has appointed Kevin Tang, the current board chair, as its new Chief Executive Officer. This leadership transition marks a significant moment for the company as it navigates its strategic path forward. Tang's appointment is expected to bring continuity and fresh perspectives to Aurinia's operations and growth initiatives within the biopharmaceutical sector.